Disclosure 0001933414-26-000118-2

SEC FORM 4

$58,785.30

Mineralys Therapeutics, Inc. (MLYS)

Sale of 2,170 shares at $27.09 per share.

Reporting Person Rodman David Malcom · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001933414-26-000118 · filed 2026-08-12 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Mineralys Therapeutics, Inc. (MLYS)." Disclosed 2026-08-12. https://desqlong.com/cards/0001933414-26-000118-2 (retrieved 2026-09-26).